Prenatal dexamethasone exposure in the common marmoset monkey enhances gene expression of antioxidant enzymes in the aorta of adult offspring

Stress

Volumn 12, Issue 3, 2009, Pages 215-224

  Atanasova, S ^a   Wieland, E ^b   Schlumbohm, C ^c   Korecka, M ^d   Shaw, L ^d   Von Ahsen, N ^a   Fuchs, E ^c   Oellerich, M ^a   Armstrong, V ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b KATHARINENHOSPITAL   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antioxidant enzymes; Dexamethasone; F2 isoprostanes; Oxidative stress; Prenatal programming

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DEXAMETHASONE; ENZYME; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE REDUCTASE; ISOPROSTANE DERIVATIVE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; 5 F(2T) ISOPROSTANE; 5-F(2T)-ISOPROSTANE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; GLUTATHIONE PEROXIDASE; PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PROSTAGLANDIN F2 ALPHA; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; AORTA; ARTICLE; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; IN VIVO STUDY; MARMOSET; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; PROSTAGLANDIN URINE LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIBLING; THIRD TRIMESTER PREGNANCY; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; MALE; METABOLISM; PRENATAL EXPOSURE; TIME;

ANIMALS; ANTIOXIDANTS; AORTA; CALLITHRIX; CATALASE; DEXAMETHASONE; DINOPROST; F2-ISOPROSTANES; FEMALE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 67949085241     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.1080/10253890802305075     Document Type: Article

References (36)

1. Ahlbom E, Gogvadze V, Chen M, Celsi G, Ceccatelli S. 2000. Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death. Proc Natl Acad Sci USA 97: 14726-14730
2. Asayama K, Hayashibe H, Dobashi K, Uchida N, Kato K. 1992. Effect of dexamethasone on antioxidant enzymes in fetal rat lungs and kidneys. Biol Neonate 62:136-144
3. Atanasova S, von Ahsen N, Schlumbohm C, Wieland E, Oellerich M, Armstrong VW. 2006. Marmoset glutathione peroxidases: cDNAs sequencies, molecular evolution and gene expression. J Med Primatol 35:155-164
4. Barker DJ. 1995. Fetal origin of coronary heart disease BMJ 311:171-174
5. Barker DJ. 2004. The development origin of adult disease. J Am Coll Nitr 23:588S-595S
6. Brown RW, Chapman KE, Kotelevtsev Y, Yau JL, Lindsay RS, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CR, Seckl JR. 1996. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Bio-chem J 313:1007-1017
7. Chen M, Bao W, Ceccatelli S, Celsi G. 2004. Prenatal exposure to high level of glucocorticoids increases the susceptibility of renal proximal tubular cells to apoptosis induced by uropathogenic Escherichia coli toxins. Am J Nephrol 24: 497-502
8. Cracowski JL, Durand T. 2006. Cardiovascular pharmacology and physiology of the isoprostanes. Fundam Clin Pharmacol 20: 417-427
9. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, Harding JE. 2005. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomized controlled trial. Lancet 365:1856-1862
10. de Vries A, Holmes MC, Heijnis A, Seier JV, Heerden J, Louw J, Wolfe-Coote S, Meaney MJ, Levitt NS, Seckl JR. 2007. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest 117:1058-1067
11. Doyle LW, Ford GW, Davis NM, Callanan C. 2000. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci 98:137-142
12. Frank L, Lewis PL, Sosenko IR. 1985. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 75:569-574
13. HaschkeM, Zhang YL, KahleC,KlawitterJ,KoreckaM,Shaw LM, Christians U. 2007. HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma. Clin Chem 53:489-497
14. Hauser J, Dettling-Artho A, Pilloud S, Maier C, Knapman A, Feldon J, Pryce CR. 2007. Effects of prenatal dexamethasone treatment on postnatal physical, endocrine, and social development in the common marmoset monkey. Endocrinology 148: 1813-1822
15. Hodge DR, Xiao W, Peng B, Cherry JC, Munroe DJ, Farrar WL. 2005. Enforced expression of superoxide dismutase 2/ manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. Cancer Res 65: 6255-6263
16. Inoue N, Ramasamy S, Fukai T, Nerem RM, Harrison DG. 1996. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 79: 32-37
17. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T. 2003. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81-87
18. Kinscherf R, Deigner HP, Usinger C, Pill J, Wagner M, Kamencic H, Hou D, Chen M, Schmiedt W, Schrader M, Kovacs G, Kato K, Metz J. 1997. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: Its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 11:1317-1328
19. Lindsay RS, Lindsay RM, Waddell BJ, Seckl JR. 1996. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: Studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39:1299-1305
20. Luo ZC, Fraser WD, Julien P, Deal CL, Audibert F, Smith GN, Xiong X, Walker M. 2006. Tracing the origins of "fetal origins" of adult diseases: Programming by oxidative stress? Med Hypotheses 66:38-44
21. Meilhac O, Zhou M, Santanam N, Parthasarathy S. 2000. Lipid peroxides induce expression of catalase in cultured vascular cells. J Lipid Res 41:1205-1213
22. Morrison TB, Weis JJ, Wittwer CT. 1998. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24:954-962
23. Napoli C, Witztum JL, de Nigris F, Palumbo G, D?Armiento FP, Palinski W. 1999. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 99: 2003-2010
24. Napoli C, Witztum JL, Calara F, de Nigris F, Palinski W. 2000. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: An experimental model of atherogenic mechanisms in human fetuses. Circ Res 87:946-952
25. Palinski W. 2003. United they go: Conjunct regulation of aortic antioxidant enzymes during atherogenesis. Circ Res 93: 183-185
26. Rahman I, Antonicelli F, MacNee W. 1999. Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J Biol Chem 274:5088-5096
27. Rajashree S, Puvanakrishnan R. 1998. Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats. Mol Cell Biochem 181:77-85
28. Roberts LJ, Morrow JD. 2000. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513
29. Seckl JR, Cleasby M, Nyirenda MJ. 2000. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int 57:1412-1417
30. Seckl JR. 2004. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 151(Suppl 3):U49-U62
31. Suzuki H, Swei A, Zweifach BW, Schmid-Schönbein GW. 1995. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: Hydroethidine microfluorography. Hypertension 25:1083-1089
32. Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, Twisk J 2003. Aorta of apoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 93, 262-269
33. Takeshita S, Inoue N, Ueyama T, Kawashima S, Yokoyama M. 2000. Shear stress enhances glutathione peroxidase expression in endothelial cells. Biochem Biophys Res Commun 273: 66-71
34. Thomassin H, Flavin M, Espinas ML, Grange T. 2001. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J 20:1974-1983
35. Welberg LA, Seckl JR, Holmes MC. 2000. Inhibition of 11beta- hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. Eur J Neurosci 12:1047-1054
36. Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KU, Whitworth JA. 2004. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 17:260-265